Dbv Technologies SA Schedule 13G passive stakes

RA Capital Management, along with affiliated entities, has reported a beneficial ownership of 5.8% in DBV Technologies, holding over 18.2 million ordinary shares.

Adage Capital Management, L.P. has reported beneficial ownership of 7.31% of DBV Technologies S.A. ordinary shares, including shares issuable upon conversion of preferred stock and exercise of warrants.

Artisan Partners Asset Management Inc. and its affiliates have reported beneficial ownership of 3.7% of DBV Technologies S.A. American Depositary Shares.

Vivo Opportunity Fund Holdings and related entities report a combined beneficial ownership of approximately 4.5% in DBV Technologies S.A.

Invus Public Equities, L.P. and affiliated entities have reported beneficial ownership of 19,310,005 ordinary shares, representing 6.5% of DBV Technologies S.A.

Vivo Opportunity Fund Holdings and affiliates report a 5.7% beneficial ownership stake in DBV Technologies S.A. ordinary shares.

Invus Public Equities and Avicenna Life Sci Master Fund, along with related entities and Raymond Debbane, reported beneficial ownership of 6.2% of DBV Technologies S.A.'s ordinary shares.

Artisan Partners Asset Management Inc. and its affiliates have reported a 7.0% beneficial ownership stake in DBV Technologies S.A. American Depositary Shares.

Janus Henderson Group plc has reported an 8.8% beneficial ownership stake in DBV Technologies S.A., holding 20,469,392 shares as of December 31, 2025.

Janus Henderson Group plc has reported a 2.6% beneficial ownership stake in DBV Technologies S.A., holding 5,272,532 common shares.

Janus Henderson Group plc has reported a 9.5% beneficial ownership stake in DBV Technologies S.A., holding over 20 million common shares.

Venrock Healthcare Capital Partners and its affiliates have reported a collective 8.2% beneficial ownership stake in DBV Technologies S.A., totaling 11,929,079 ordinary shares.

Invus Public Equities, Avicenna Life Sci Master Fund, and Raymond Debbane collectively reported beneficial ownership of 7.8% of DBV Technologies S.A.'s Ordinary Shares.

A group of Venrock Healthcare Capital Partners entities and individuals reported a collective 9.8% beneficial ownership stake in DBV Technologies S.A. as of June 30, 2025.

Adage Capital Management and its principals have disclosed a 9.99% beneficial ownership stake in DBV Technologies S.A., including shares and warrants.

Citadel Advisors LLC, its affiliates, and Kenneth Griffin have disclosed a combined passive beneficial ownership of 6.4% in DBV Technologies S.A., totaling 9,194,107 ordinary shares.

Suvretta Capital Management, LLC, Aaron Cowen, and Averill Master Fund, Ltd. have jointly disclosed a passive beneficial ownership of up to 9.9% in DBV Technologies S.A., primarily through ordinary shares and pre-funded warrants.

Vivo Opportunity Fund Holdings, L.P. and its affiliates have disclosed a passive beneficial ownership of 9.99% in DBV Technologies S.A., primarily through a combination of ordinary shares and warrants.

Braidwell LP, Braidwell Management LLC, Alexander T. Karnal, and Brian J. Kreiter have jointly reported a 2.5% beneficial ownership stake in DBV Technologies S.A. as of December 31, 2024.